Grafico Azioni Lloyds Banking (LSE:LLOY)
2 Mesi : Da Ott 2019 a Dic 2019
RNS Number : 0293S
Lloyds Banking Group PLC
01 November 2019
1 November 2019
Publication of Supplementary Prospectus
The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing:
Supplementary Prospectus dated 1 November 2019 (the "Supplementary Prospectus") relating to the GBP25,000,000,000 Euro Medium Term Note Programme of Lloyds Banking Group plc.
The Supplementary Prospectus should be read and construed in conjunction with the base prospectus dated 8 April 2019, as supplemented by the supplementary prospectuses dated 2 May 2019, 31 July 2019 and 10 September 2019 (together, the "Base Prospectus").
To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:
The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.
For further information, please contact:
Group Investor Relations Director
Tel: +44 20 7356 1571
Head of Corporate Media
Tel: +44 20 7356 3522
Lloyds Banking Group plc
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.
In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and Base Prospectus.
Your right to access this service is conditional upon complying with the above requirement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.
(END) Dow Jones Newswires
November 01, 2019 10:05 ET (14:05 GMT)